# Monopar Therapeutics (MNPR) - Q4 2024 earnings

Reported March 31, 2025.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | - | Not available |
| EPS | $-2.23 | $-0.36 |

Earnings filing reader: [8-K 0001437749-25-009982](https://www.opencapital.sh/filings/0001437749-25-009982)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001437749-25-009982.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1645469/0001437749-25-009982-index.htm)
Periodic report: 10-K - https://www.sec.gov/Archives/edgar/data/1645469/0001437749-25-009979-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/mnpr/earnings/q4-2024